4-70202765-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017855.4(ODAM):c.658G>A(p.Glu220Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,609,486 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017855.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ODAM | NM_017855.4 | c.658G>A | p.Glu220Lys | missense_variant | 10/12 | ENST00000683306.1 | NP_060325.3 | |
ODAM | NM_001385579.1 | c.610G>A | p.Glu204Lys | missense_variant | 9/11 | NP_001372508.1 | ||
ODAM | XM_047415863.1 | c.709G>A | p.Glu237Lys | missense_variant | 10/11 | XP_047271819.1 | ||
ODAM | XM_047415864.1 | c.667G>A | p.Glu223Lys | missense_variant | 9/11 | XP_047271820.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000791 AC: 12AN: 151742Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000324 AC: 8AN: 247074Hom.: 0 AF XY: 0.0000224 AC XY: 3AN XY: 133806
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1457744Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 725160
GnomAD4 genome AF: 0.0000791 AC: 12AN: 151742Hom.: 0 Cov.: 32 AF XY: 0.0000945 AC XY: 7AN XY: 74064
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.658G>A (p.E220K) alteration is located in exon 9 (coding exon 9) of the ODAM gene. This alteration results from a G to A substitution at nucleotide position 658, causing the glutamic acid (E) at amino acid position 220 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at